Omalizumab for chronic urticaria in Latin America
Abstract Background Chronic urticaria (CU) is defined as the spontaneous appearance of wheals, with or without angioedema, persisting for ≥6 weeks. Chronic Spontaneous Urticaria (CSU) is a type of CU which affects 0.5–1 % of the global population, but it represents a high burden to patients. In rece...
Main Authors: | Paul Wilches, Paola Wilches, Juan Carlos Calderon, Annia Cherrez, Ivan Cherrez Ojeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-11-01
|
Series: | World Allergy Organization Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40413-016-0127-y |
Similar Items
-
Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012-01-01) -
Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01) -
Omalizumab for treatment of chronic urticaria: A review of effective dose
by: javad Ghaffari, et al.
Published: (2019-03-01) -
Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
by: Murat Türk, et al.
Published: (2018-01-01) -
Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
by: Pasquale Comberiati, et al.
Published: (2019-07-01)